Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Shuguang Qin"'
Autor:
Zhaohui Ni, Haijiao Jin, Renhua Lu, Lihong Zhang, Li Yao, Guojian Shao, Li Zuo, Shuguang Qin, Xinzhou Zhang, Qinghong Zhang, Weimin Yu, Qun Luo, Yuqing Ren, Hui Peng, Jie Xiao, Qiongqiong Yang, Qinkai Chen, Yifan Shi, the PRECEDE-K study group
Publikováno v:
BMC Nephrology, Vol 24, Iss 1, Pp 1-9 (2023)
Abstract Background Hyperkalaemia is a known risk factor for cardiac arrhythmia and mortality in patients on haemodialysis. Despite standard adequate haemodialysis, hyperkalaemia is common in patients with end-stage renal disease (ESRD) at interdialy
Externí odkaz:
https://doaj.org/article/dd5072fd393249308ae464ec96b0bbd5
Autor:
Ping Zhang, Yan Jiang, Chunping Xu, Linghui Zhou, Hongguang Zheng, Deqiong Xie, Minghao Guo, Xiangyang Huang, Guoyuan Lu, Hongli Jiang, Hongyu Qiu, Bicheng Liu, Shaomei Li, Qinkai Chen, Yu'ou Xia, Bengui Sun, Xiao Yang, Shiying Zhang, Shutong Du, Mindan Sun, Menghua Chen, Aimin Zhong, Xiaoling Wang, Zhanzheng Zhao, Hua Zhou, Guisen Li, Yueqin Ren, Qun Luo, Aicheng Yang, Ping Luo, Shuifu Tang, Chengyun Xu, Qin Wang, Xiaoxia Wang, Tiekun Yan, Wei He, Shuguang Qin, Weili Zhang, Lu Lv, Cheng Wang, Hong Liu, Jing Li, Qiong Wu, Chao Pan, Chuan Li, Liangliang He, Jianghua Chen
Publikováno v:
EClinicalMedicine, Vol 65, Iss , Pp 102273- (2023)
Summary: Background: Pegmolesatide, a synthetic peptide-based erythropoietin (EPO) receptor agonist, is being evaluated as an alternative to epoetin alfa for treating anemia of chronic kidney disease (CKD) in Chinese dialysis patients. There is a cri
Externí odkaz:
https://doaj.org/article/6691532a57474e01b73b507ab1143e8f
Autor:
Shuguang Qin, Zhenjun Tian, Maxime Boidin, Benjamin J. R. Buckley, Dick H. J. Thijssen, Gregory Y. H. Lip
Publikováno v:
Frontiers in Physiology, Vol 13 (2022)
Background: Regular exercise is an effective non-pharmacological therapy for treatment and prevention of cardiovascular disease (CVD). The therapeutic benefits of exercise are mediated partly through improved vascular and increase in metabolic health
Externí odkaz:
https://doaj.org/article/1d96193d95414e55b5ba417012b27579
Autor:
Tao Wang, Mengyuan Yu, Hangzhuo Li, Shuguang Qin, Wujing Ren, Yixuan Ma, Wenyan Bo, Yue Xi, Mengxin Cai, Zhenjun Tian
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 4, p 4159 (2023)
Myocardial infarction (MI) causes peripheral organ injury, in addition to cardiac dysfunction, including in the liver, which is known as cardiac hepatopathy. Aerobic exercise (AE) can effectively improve liver injury, although the mechanism and targe
Externí odkaz:
https://doaj.org/article/70d50d82d0c6410e84fedbeb5f690dff
Publikováno v:
BMC Molecular and Cell Biology, Vol 20, Iss 1, Pp 1-9 (2019)
Abstract Background Hypertrophic cardiomyopathy occurs along with pathological phenomena such as cardiac hypertrophy, myocardial fibrosis and cardiomyocyte activity. However, few of the specific molecular mechanisms underlying this pathological condi
Externí odkaz:
https://doaj.org/article/05917d99a185494eb5718c2b79daa345
Autor:
Ming Lei, Kashuai Lin, Yaoqiu Pi, Xiaomei Huang, Lixin Fan, Jun Huang, Riguang Liu, Lin Liu, Xinning Shao, Kaiyuan Hu, Liuping Yang, Shuguang Qin, Feng He
Publikováno v:
Journal of Diabetes Research, Vol 2020 (2020)
Introduction. Previous studies of coronavirus disease 2019 (COVID-19) have focused on the general population. However, diabetes (DM) as one of the most common comorbidities is rarely studied in detail. This study is aimed at describing clinical chara
Externí odkaz:
https://doaj.org/article/f7f92d974f694f14a021a0589a210196
Publikováno v:
Biomedicines, Vol 9, Iss 6, p 701 (2021)
Myocardial infarction is the major cause of death in cardiovascular disease. In vitro and in vivo models are used to find the exercise mode which has the most significant effect on myocardial irisin/FNDC5 expression and illuminate the cardioprotectiv
Externí odkaz:
https://doaj.org/article/f78d10d18d0849f993ed3ab407e0630c
Autor:
Shuguang Qin1,2,3, Boidin, Maxime1,2,4,5, Buckley, Benjamin J. R.1, Lip, Gregory Y. H.1, Thijssen, Dick H. J.1,2,6 D.Thijssen@ljmu.ac.uk
Publikováno v:
European Journal of Clinical Investigation. May2021, Vol. 51 Issue 5, p1-12. 12p.
Publikováno v:
Computer Methods and Programs in Biomedicine. 235:107519
Publikováno v:
Frontier Research: Road and Traffic Engineering ISBN: 9781003305002
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9d2e076e3f2633e5e9b715c0e34a80b1
https://doi.org/10.1201/9781003305002-7
https://doi.org/10.1201/9781003305002-7